Achieve Life Sciences ACHV
NASDAQ ACHV
$6.78 +0.06 (+0.89%)
At close: Nov 9, 2026 · 4:00 PM EST

Achieve Life Sciences (ACHV) Cash from Restructuring (2010 - 2015)

Updated

Achieve Life Sciences (ACHV) recorded Cash from Restructuring of -$194,000 in FY2015, compared with -$785,000 in FY2014.

Analysis

Achieve Life Sciences (ACHV) Cash from Restructuring (2010 - 2015) Analysis & Trends

Starting with FY2011, Achieve Life Sciences' Cash from Restructuring history includes 5 years.

  • The FY2015 figure is the highest annual Cash from Restructuring in data going back to FY2011.
  • Per Business Quant data, ACHV's Cash from Restructuring was -$785,000 in FY2014, -$680,000 in FY2013, -$795,000 in FY2012 and -$407,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Achieve Life Sciences 696.42 Mn 509.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 -194,000.00
Dec 31, 2014 -267,000.00
Sep 30, 2014 -199,000.00
Jun 30, 2014 -194,000.00
Mar 31, 2014 -189,000.00
Dec 31, 2013 -176,000.00
Sep 30, 2013 -173,000.00
Jun 30, 2013 -167,000.00
Mar 31, 2013 -164,000.00
Dec 31, 2012 -1.66 Mn
Sep 30, 2010 4.04 Mn
API Access

Achieve Life Sciences Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=ACHV&period=max&api_key=YOUR_API_KEY